faculty

SHOW Co-Chairs

Wendy Lam, BSc. (Pharm), MD, FRCPC

Hematologist and Medical Oncologist
Burnaby Hospital Regional Cancer Center
Director, BC Community Oncology Trialists
Burnaby, BC

Dr. Wendy Lam is a hematologist and medical oncologist at the Burnaby Hospital Regional Cancer Centre.

She received her B.Sc (Pharmacy) at Dalhousie University and her MD from University of British Columbia. She then completed her Internal Medicine residency at UBC and Hematology fellowship at McMaster University.

She is the Founding Director of the British Columbia Community Oncology Trialists (BC Cot), which is a collaborative group of oncologists and hematologists involved in clinical research.

Her other interests include education of patients through meeting with patient groups. She has also been instrumental in organizing meetings for continued medical education.

She is Director of the Society of Hematology and Oncology of BC at British Columbia Medical Association.

She is Director of the Society of Hematology and Oncology of BC at British Columbia Medical Association

David Liu, MD, FRCPC, FSIR

Associate Professor, Department of Radiology, Faculty of Medicine, University of British Columbia
Associate Professor, School of Biomedical Engineering, Faculty of Applied Sciences, University of British Columbia
Voluntary Professor, Department of Interventional Radiology, Miller School of Medicine, University of Miami
Vancouver, BC

Dr. David M Liu MD is a board certified in both Canada and the US, practicing at the Vancouver General Hospital, University of British Columbia Hospital and the BC Cancer Agency with a cross appointment in the Department of Surgery. Dr. Liu received his medical degree from University of Toronto, completed his radiology residency at University of British Columbia, Interventional Radiology fellowship at Northwestern Memorial Hospital, and has practiced in both the US and Canada.

In addition to benchside and clinical research in the fields of novel embolic platforms, ablative technologies and cancer related thromboembolic disease, Dr. Liu maintains an interventional oncology practice incorporating all aspects of embolization, ablation, venous access, and palliative therapy in all organ systems. He is the co-founder and co-chair of the international liver cancer symposium, SHOW, and has been credited with 7 book chapters, over 70 publications, and over 100 invited lectures around the world. Dr. Liu an active member of the interventional radiology community as recognized through his induction as a Fellow of the Society of Interventional Radiology, and has been awarded the CIRA award from the Canadian Association of Interventional Radiology (CAIR) in recognition of his extraordinary contribution to the practice of IR in Canada and worldwide.

Dr. Liu holds numerous academic appointments including:

Associate Professor, Faculty of Medicine, Department of Radiology, University of British Columbia, Vancouver, Canada

Associate Professor, Faculty of Applied Sciences, School of Biomedical Engineering, University of British Columbia, Vancouver, Canada

Voluntary Professor, Miller School of Medicine, Department of Interventional Radiology, Miami, USA

Andrew Kennedy, MD, FACRO (Interventional Radiology)

Physician in Chief, Radiation Oncology, Sarah Cannon
Director, Radiation Oncology Research, Sarah Cannon Research Institute
Sarah Cannon Cancer Center
Nashville, TN

Dr. Kennedy joined Sarah Cannon in 2012 as the Physician in Chief, Radiation Oncology and Director, Radiation Oncology Research at Sarah Cannon Research Institute where he is responsible for strategic development of radiation oncology services for HCA Healthcare and development of radiation oncology research program within Sarah Cannon to complement the world-class medical oncology program. Dr. Kennedy is a graduate of the Loma Linda School of Medicine in California, and completed his residency at The University of North Carolina at Chapel Hill.

He is an internationally renowned radiation oncologist specializing in gastrointestinal cancers, as well as cancers of the breast and lung. Nationally, he served as a member of the Board of Chancellors for the American College of Radiation Oncology and is a Fellow of the College. He has been selected yearly since 2009 as one of America’s Best Doctors (top 5 percent of U.S.), and was inducted into Alpha Omega Alpha (AOA) Honor Society as a faculty member in 1999.

Peter TW Kim MD, MSc, FRCSC, FACS

Head, Liver Transplant Program
Head, Hepatopancreatobiliary Surgery
Vancouver General Hospital
Clinical Associate Professor
University of British Columbia
Vancouver, BC

Dr. Peter Kim is a liver transplant and a hepatopancreatobiliary (HPB) surgeon at the Vancouver General Hospital and an associate clinical professor of the Department of Surgery, University of British Columbia. He is the current head of the liver transplant and the HPB surgery program at the Vancouver General Hospital.

Dr. Kim received his medical degree from the University of Western Ontario in London, Ontario, Canada. He completed his general surgery residency and Masters of Sciences degree at the University of British Columbia. His research work focused on differentiating embryonic stem cells into insulin producing cells to treat diabetes. He subsequently completed his abdominal transplant surgery fellowship at Baylor University Medical Center, Dallas, Texas, followed by HPB surgery fellowship at the University of Toronto.

After his training, Dr. Kim worked at the Baylor University Medical Center as the assistant director of living donor liver transplantation for 5 years before returning to the Vancouver General Hospital to join the liver transplantation team. His clinical practice includes liver transplantation and hepatopancreatobiliary surgery.

Dr. Kim is an author of over 60 publications and 8 book chapters. His research interests include studying the importance of blood flow to the liver in liver transplantation, bile duct complications in liver transplantation and complex surgical resections in pancreas cancer surgery.